Even companies like Amgen and Novartis, still in early or limited stages in this space, are investing heavily in metabolic disease pipelines, signaling that the race for dominance in obesity and diabetes therapeutics is far from over and will only intensify as global prevalence of these conditions continues to rise
Tirzepatide is also less effective at reducing body weight in T2D patients compared to patients without (15.7% weight loss, SURMOUNT-2 and 22.5% weight loss, SURMOUNT-1, respectively)
Like any medication, the decision is a risk/benefit one
Increase GLP-1 Naturally 2
This could be a potential problem if you already have high levels of iron in your body
Antioxidants: These can reduce oxidative stress, improve immune function and reduce inflammation, helping with weight management